Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44093
- Centre Hospitalier Universitaire de Nantes
-
Paris, France, 75019
- Hopital Robert Debre
-
Paris, France, 75019
- Hôpital Cochin Port Royal
-
Toulouse, France, 31026
- Hopital Paule de Viguier - CHU Toulouse
-
Tours, France, 37044
- Centre Hospitalier Regional et Universitaire - Hopital Bretonneau
-
-
-
-
Alabama
-
Mobile, Alabama, United States, 36604-3302
- University of South Alabama
-
-
California
-
La Mesa, California, United States, 91942
- Grossmont Center for Clinical Research
-
San Diego, California, United States, 92123
- San Diego Perinatal Center
-
San Diego, California, United States, 92121
- IGO
-
San Diego, California, United States, 92123
- Women's Healthcare at Frost Street
-
San Diego, California, United States, 92128
- Poway Womens Care
-
-
Florida
-
Boynton Beach, Florida, United States, 33472
- Visions Clinical Research
-
Miami, Florida, United States, 33136
- University of Miami
-
Miami, Florida, United States, 33143
- South Florida Perinatal Medicine
-
Pembroke Pines, Florida, United States, 33323
- Global Ob/Gyn Centers
-
Sunrise, Florida, United States, 33323
- Sheridan Clinical Research
-
Sunrise, Florida, United States, 33323
- Discovery Clinical Research
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96814
- Fetal Diagnostic Institution of the Pacific
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Women's Clinic
-
-
Illinois
-
Chicago, Illinois, United States, 60602
- Reproductive Genetics Institute
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- Spectrum Health - Maternal Fetal Medicine
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Missouri
-
St Louis, Missouri, United States, 63117
- St Louis University
-
-
Nebraska
-
Omaha, Nebraska, United States, 68022
- Methodist Hospital
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Cooper University Hospital
-
-
North Carolina
-
Winston Salem, North Carolina, United States, 27103
- Lyndhurst Gynecologic Associates
-
-
Ohio
-
Columbus, Ohio, United States, 43231
- Complete Healthcare For Women
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Clinical Trials of America
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Tennessee
-
Kingsport, Tennessee, United States, 37660
- Kingsport Perinatology
-
Nashville, Tennessee, United States, 37203
- Perinatal Research Center
-
Nashville, Tennessee, United States, 37203
- Tenessee Maternal Fetal Medicine
-
-
Texas
-
Houston, Texas, United States, 77054
- Houston Perinatal Associates
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject is female
- Subject is pregnant
- Subject is 18 years of age or older
- Subject provides a signed and dated informed consent
- Subject agrees to provide a 30-50mL blood sample
- Subject is at increased risk for Down syndrome or other aneuploidies (greater than or equal to 35 years of age at time of delivery, elevated risk by maternal serum markers including Triple, Quad and integrated test, fetal birth defects or markers identified by ultrasound or family history of aneuploidy).
- Subject plans to undergo an amniocentesis and/or CVS procedure
- Subject agrees that the FISH, karyotype, and/or QF-PCR results obtained via the invasive procedure will be provided
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Allan T Bombard, MD, Sequenom, Inc.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Heart Defects, Congenital
- Cardiovascular Abnormalities
- Abnormalities, Multiple
- Chromosome Disorders
- Chromosome Aberrations
- Syndrome
- Down Syndrome
- Aneuploidy
- Trisomy 18 Syndrome
Other Study ID Numbers
Other Study ID Numbers
- SQNM-T21-202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.